Latest California Healthline Stories
Death Threats And Subpoenas: How Congress’ Fetal Research Probe Turned A Tiny Company Upside Down
StemExpress is a small biomedical company based in California, and its work with fetal tissue has catapulted it into the national spotlight.
When Traditional Medicine Failed Them, Parents Of Epileptic Boy Turned To A Controversial Treatment
The Sacramento Bee follows a couple’s journey in treating their 3-year-old son who has a life-threatening form of epilepsy. Forrest and Nicole Hurd didn’t realize that search for a cure would pull them into a deepening rift over the use of medical marijuana.
Critics Slam Gilead For Halting Development Of Less-Toxic HIV Treatment
They say the company made the decision so that it could continue to reap patent-protected profits from its earlier version. Gilead denies the claims.
Drugmakers, Medical Groups Take Sides On Drug Pricing Ballot Initiative
A proposal to cap the costs of prescription drugs is among the state’s 19 measures up for a vote this November that are attracting record spending by opponents and advocates. Meanwhile, several doctors associations are joining efforts to defeat the initiative, titled the California Drug Price Relief Act.
California Looks For Aid-In-Dying Lessons From Experiences Of Oregon, Washington
As the June 9 start of California’s controversial law approaches, state officials can look to annual reports by public health departments in Oregon and Washington, where similar measures are already in effect.
Organ Transplants Between HIV-Positive Patients Now Legal In California
Gov. Jerry Brown signed the measure lifting a ban on the procedure after state legislators fast-tracked legislation. The rush was prompted in part by the case of a man with HIV who needed to receive part of his HIV-positive husband’s liver before the surgery becomes too dangerous.
Viewpoints: How Much Should A Physician Do To Save A Life?
A selection of opinions on health care developments from around the state.
CDC Head: The Window Is Closing On Opportunity To Effectively Fight Zika
On the same day Congress left town without approving money to fight the outbreak, Dr. Tom Frieden, the head of the Centers for Disease Control and Prevention, warned that time is running out. He knows how to change the course of an epidemic, he says, but he can’t because his hands are tied on funding. Key House Republicans say, however, that more money will be coming and the government’s efforts have not been hamstrung.
FDA Approves First-Of-Its-Kind Implant To Treat Opioid Addiction
Proponents say the method of using implants instead of pills could help patients avoid dangerous relapses that can occur if they miss a medication dose.
Discovery Of Superbug In U.S. Could Signal ‘End Of The Road’ For Antibiotics
Defense Department researchers have determined that a Pennsylvania woman carried a strain of E. coli resistant to the antibiotic colistin, a discovery that could lead to a “nightmare” situation where infections are untreatable.